Validation and functional follow‐up of cervical cancer risk variants at the HLA locus
HLA · 2024
DOI: 10.1111/tan.15597 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Rieke Eisenblätter und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, Comprehensive Cancer Center, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Genome-Wide Association Study, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bruno and Helene Jöster foundation, TumorStiftung Plus at Hannover Medical School, Hannover Biomedical Research School.
Abstract (Originalsprache)
Cervical cancer is the fourth most common cancer in females. Genome‐wide association studies (GWASs) have proposed cervical cancer susceptibility variants at the HLA locus on chromosome 6p21. To corroborate these findings and investigate their functional impact in cervical tissues and cell lines, we genotyped nine variants from cervical cancer GWASs (rs17190106, rs535777, rs1056429, rs2763979, rs143954678, rs113937848, rs3117027, rs3130214, and rs9477610) in a German hospital‐based series of 1122 invasive cervical cancers, 1408 dysplasias, and 1196 healthy controls. rs17190106, rs1056429 and rs143954678/rs113937848 associated with cervical malignancies overall, while rs17190106 and rs535777 associated specifically with invasive cancer (OR = 0.69, 95% CI = 0.55–0.86, p = 0.001) or adenocarcinomas (OR = 1.63, 95%CI = 1.17–2.27, p = 0.004), respectively. We tested these and one previously genotyped GWAS variant, rs9272117, for potential eQTL effects on 36 gene transcripts at the HLA locus in 280 cervical epithelial tissues. The strongest eQTL pairs were rs9272117 and HLA‐DRB6 ( p = 1.9x10E‐5), rs1056429 and HLA‐DRB5 ( p = 2.5x10E‐4), and rs535777 and HLA‐DRB1 ( p = 2.7x10E‐4). We also identified transcripts that were specifically upregulated ( DDX39B , HCP5 , HLA‐B , LTB , NFKBIL1 ) or downregulated ( HLA‐C , HLA‐DPB2 ) in HPV+ or HPV16+ samples. In comparison, treating cervical epithelial cells with proinflammatory cytokine γ‐IFN led to a dose‐dependent induction of HCP5 , HLA‐B , HLA‐C , HLA‐DQB1 , HLA‐DRB1 , HLA‐DRB6 , and repression of HSPA1L . Taken together, these results identify relevant genes from both the MHC class I and II regions that are inflammation‐responsive in cervical epithelium and associate with HPV ( HCP5 , HLA‐B , HLA‐C ) and/or with genomic cervical cancer risk variants ( HLA‐DRB1 , HLA‐DRB6 ). They may thus constitute important contributors to the immune escape of precancerous cells after HPV‐infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology, Comprehensive Cancer Center, Hannover Medical School, Hannover, Germany.
- IZD Hannover, Hannover, Germany.
- Department of Gynaecology, University Clinics, Martin-Luther University, Halle-Wittenberg, Germany.
- Department of Gynaecology, Clinics Carl Gustav Carus, University of Dresden, Dresden, Germany.
- Department of Gynaecology, Technische Universität München, Munich, Germany.
- Martin-Luther Hospital, Charite University, Berlin, Germany.
ORCID-Profile: Thilo Dörk, Dhanya Ramachandran
Förderung
- Bruno and Helene Jöster foundation
- TumorStiftung Plus at Hannover Medical School
- Hannover Biomedical Research School
Zitieren
APA
Eisenblätter, R., Seifert, F., Schürmann, P., Beckhaus, T., Hanel, P., Jentschke, M., Böhmer, G., Strauß, H. G., Hirchenhain, C., Schmidmayr, M., Müller, F., Hein, A., Stuebs, F., Koch, M., Ruebner, M., Beckmann, M. W., Fasching, P. A., Luyten, A., Häfner, N., …, & Ramachandran, D. (2024). Validation and functional follow‐up of cervical cancer risk variants at the HLA locus. HLA. https://doi.org/10.1111/tan.15597
Vancouver
Eisenblätter R, Seifert F, Schürmann P, Beckhaus T, Hanel P, Jentschke M, et al. Validation and functional follow‐up of cervical cancer risk variants at the HLA locus. HLA. 2024. doi:10.1111/tan.15597
BibTeX
@article{Eisenbltter2024,
author = {Eisenblätter, Rieke and Seifert, Finja and Schürmann, Peter and Beckhaus, Theresa and Hanel, Patricia and Jentschke, Matthias and Böhmer, Gerd and Strauß, Hans-Georg and Hirchenhain, Christine and Schmidmayr, Monika and Müller, Florian and Hein, Alexander and Stuebs, Frederik and Koch, Martin and Ruebner, Matthias and Beckmann, Matthias W and Fasching, Peter A and Luyten, Alexander and Häfner, Norman and Hillemanns, Peter and Dörk, Thilo and Ramachandran, Dhanya},
title = {Validation and functional follow‐up of cervical cancer risk variants at the HLA locus},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15597}
}
EUVIMED